Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice

Abstract Background Intracellular deposition of alpha‐synuclein (α‐syn) as Lewy bodies and Lewy neurites is a central event in the pathogenesis of Parkinson's disease (PD) and other α‐synucleinopathies. Transgenic mouse models overexpressing human α‐syn, are useful research tools in preclinical...

Full description

Bibliographic Details
Main Authors: Agata Aniszewska, Joakim Bergström, Martin Ingelsson, Sara Ekmark‐Lewén
Format: Article
Language:English
Published: Wiley 2022-07-01
Series:Brain and Behavior
Subjects:
Online Access:https://doi.org/10.1002/brb3.2628
_version_ 1817971270375964672
author Agata Aniszewska
Joakim Bergström
Martin Ingelsson
Sara Ekmark‐Lewén
author_facet Agata Aniszewska
Joakim Bergström
Martin Ingelsson
Sara Ekmark‐Lewén
author_sort Agata Aniszewska
collection DOAJ
description Abstract Background Intracellular deposition of alpha‐synuclein (α‐syn) as Lewy bodies and Lewy neurites is a central event in the pathogenesis of Parkinson's disease (PD) and other α‐synucleinopathies. Transgenic mouse models overexpressing human α‐syn, are useful research tools in preclinical studies of pathogenetic mechanisms. Such mice develop α‐syn inclusions as well as neurodegeneration with a topographical distribution that varies depending on the choice of promoter and which form of α‐syn that is overexpressed. Moreover, they display motor symptoms and cognitive disturbances that to some extent resemble the human conditions. Purpose One of the main motives for assessing behavior in these mouse models is to evaluate the potential of new treatment strategies, including their impact on motor and cognitive symptoms. However, due to a high within‐group variability with respect to such features, the behavioral studies need to be applied with caution. In this review, we discuss how to make appropriate choices in the experimental design and which tests that are most suitable for the evaluation of PD‐related symptoms in such studies. Methods We have evaluated published results on two selected transgenic mouse models overexpressing wild type (L61) and mutated (A30P) α‐syn in the context of their validity and utility for different types of behavioral studies. Conclusions By applying appropriate behavioral tests, α‐syn transgenic mouse models provide an appropriate experimental platform for studies of symptoms related to PD and other α‐synucleinopathies.
first_indexed 2024-04-13T20:44:42Z
format Article
id doaj.art-a606ebf0f1954c5a8d104cce47e36bc1
institution Directory Open Access Journal
issn 2162-3279
language English
last_indexed 2024-04-13T20:44:42Z
publishDate 2022-07-01
publisher Wiley
record_format Article
series Brain and Behavior
spelling doaj.art-a606ebf0f1954c5a8d104cce47e36bc12022-12-22T02:30:44ZengWileyBrain and Behavior2162-32792022-07-01127n/an/a10.1002/brb3.2628Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing miceAgata Aniszewska0Joakim Bergström1Martin Ingelsson2Sara Ekmark‐Lewén3Department of Public Health and Caring Sciences Molecular Geriatrics Uppsala University Uppsala SwedenDepartment of Public Health and Caring Sciences Molecular Geriatrics Uppsala University Uppsala SwedenDepartment of Public Health and Caring Sciences Molecular Geriatrics Uppsala University Uppsala SwedenDepartment of Public Health and Caring Sciences Molecular Geriatrics Uppsala University Uppsala SwedenAbstract Background Intracellular deposition of alpha‐synuclein (α‐syn) as Lewy bodies and Lewy neurites is a central event in the pathogenesis of Parkinson's disease (PD) and other α‐synucleinopathies. Transgenic mouse models overexpressing human α‐syn, are useful research tools in preclinical studies of pathogenetic mechanisms. Such mice develop α‐syn inclusions as well as neurodegeneration with a topographical distribution that varies depending on the choice of promoter and which form of α‐syn that is overexpressed. Moreover, they display motor symptoms and cognitive disturbances that to some extent resemble the human conditions. Purpose One of the main motives for assessing behavior in these mouse models is to evaluate the potential of new treatment strategies, including their impact on motor and cognitive symptoms. However, due to a high within‐group variability with respect to such features, the behavioral studies need to be applied with caution. In this review, we discuss how to make appropriate choices in the experimental design and which tests that are most suitable for the evaluation of PD‐related symptoms in such studies. Methods We have evaluated published results on two selected transgenic mouse models overexpressing wild type (L61) and mutated (A30P) α‐syn in the context of their validity and utility for different types of behavioral studies. Conclusions By applying appropriate behavioral tests, α‐syn transgenic mouse models provide an appropriate experimental platform for studies of symptoms related to PD and other α‐synucleinopathies.https://doi.org/10.1002/brb3.2628alpha‐synucleinbehavioral testethologyParkinson´s diseasetransgenic mouse modelstranslational research
spellingShingle Agata Aniszewska
Joakim Bergström
Martin Ingelsson
Sara Ekmark‐Lewén
Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
Brain and Behavior
alpha‐synuclein
behavioral test
ethology
Parkinson´s disease
transgenic mouse models
translational research
title Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
title_full Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
title_fullStr Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
title_full_unstemmed Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
title_short Modeling Parkinson's disease‐related symptoms in alpha‐synuclein overexpressing mice
title_sort modeling parkinson s disease related symptoms in alpha synuclein overexpressing mice
topic alpha‐synuclein
behavioral test
ethology
Parkinson´s disease
transgenic mouse models
translational research
url https://doi.org/10.1002/brb3.2628
work_keys_str_mv AT agataaniszewska modelingparkinsonsdiseaserelatedsymptomsinalphasynucleinoverexpressingmice
AT joakimbergstrom modelingparkinsonsdiseaserelatedsymptomsinalphasynucleinoverexpressingmice
AT martiningelsson modelingparkinsonsdiseaserelatedsymptomsinalphasynucleinoverexpressingmice
AT saraekmarklewen modelingparkinsonsdiseaserelatedsymptomsinalphasynucleinoverexpressingmice